Methylprednisolone in Childhood Idiopathic Thrombocytopenic Purpura
نویسندگان
چکیده
منابع مشابه
Idiopathic thrombocytopenic purpura in childhood.
Purpura is a relatively common symptom in childhood and may be due to a variety of causes. A platelet count enables one to exclude the nonthrombocytopenic variety, but more elaborate investigations are needed to exclude other primary conditions which are often associated with thrombocytopenia, e.g. leukaemia. There remains a group of patients with idiopathic thrombocytopenic purpura and it is w...
متن کاملPrognosis in idiopathic thrombocytopenic purpura of childhood.
Many articles have been written about idiopathic thrombocytopenic purpura but few differentiate adequately between children and adults. This is unfortunate, as it is generally agreed that the disease is much milder in children than in adults, and has a better prognosis. We propose, therefore, to discuss a number of cases in children and to review some other series in order to obtain a clearer p...
متن کاملBolus methylprednisolone therapy in adult idiopathic thrombocytopenic purpura.
Eleven patients with adult idiopathic thrombocytopenic purpura (ITP) were treated with bolus methylprednisolone at doses of 1 g/day for 3 days. In nine of eleven patients the platelet count rose to more than 100 X 10(9)/l during 2-9 days. In two other patients, it rose to 81 X 10(9)/l and 43 X 10(9)/l. In six of eleven patients splenectomy was carried out without any platelet transfusion when t...
متن کاملEpidemiology of Idiopathic Thrombocytopenic Purpura in Children
Abstract Background Immune thrombocytopenic purpura (ITP) is a common autoimmune bleeding condition in children that is characterized by a decrease in the platelet count. The aims of this study were to define epidemiologic features of patients with primary ITP who were admitted to Mofid Children's Hospital, Tehran, Iran, in a 5-year period. Methods We retrospectively studied the records of ...
متن کاملHigh-dose methylprednisolone for chronic idiopathic thrombocytopenic purpura.
Prof Şinasi Özsoylu, MD, Department of Pediatrics, Hematology Unit, Faculty of Medicine, Hacettepe University, Ankara 06100 (Turkey) I have read with interest the article by Mazzucconi et al. [1] entitled ‘Danazol Therapy in Refractory Chronic Immune Thrombocytopenic Purpura’ in the recent issue of the journal. I would like to bring to the authors’ attention that marked improvement of platelet ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Haematologica
سال: 1988
ISSN: 0001-5792,1421-9662
DOI: 10.1159/000205754